Liver study tests how drug behaves in severe disease
NCT ID NCT03664544
First seen Jan 08, 2026 · Last updated May 03, 2026 · Updated 19 times
Summary
This study looked at how the drug MCI-186 moves through the body in people with severe liver damage compared to healthy people. Researchers gave a single dose to 12 adults and measured drug levels and side effects. The goal was to understand if liver problems change how the drug works, not to treat the liver condition itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Centre
Prague, Czechia
-
Investigational Centre
Miskolc, Hungary
-
Investigational Centre
Bratislava, Slovakia
Conditions
Explore the condition pages connected to this study.